These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19738988)

  • 1. Cardioprotective effect of ornitho-kinin in an anesthetized, open-chest chicken model of acute coronary occlusion.
    Prezoto BC; Couto GK; Rossoni LV; Schoorlemmer GH; Carillo BA; Campos RR
    Braz J Med Biol Res; 2009 Sep; 42(9):824-30. PubMed ID: 19738988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation.
    Miki T; Miura T; Ura N; Ogawa T; Suzuki K; Shimamoto K; Iimura O
    J Am Coll Cardiol; 1996 Nov; 28(6):1616-22. PubMed ID: 8917279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ornitho-kininogen and ornitho-kinin: isolation, characterization and chemical structure.
    Kimura M; Sueyoshi T; Morita T; Tanaka K; Iwanaga S
    Adv Exp Med Biol; 1989; 247A():359-67. PubMed ID: 2603803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of ornitho-kininogen.
    Kimura M; Sueyoshi T; Takada K; Tanaka K; Morita T; Iwanaga S
    Eur J Biochem; 1987 Nov; 168(3):493-501. PubMed ID: 3665932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
    Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H; Miatello R; Damiani MT; Abate CD
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bradykinin in myocardial preconditioning.
    Wall TM; Sheehy R; Hartman JC
    J Pharmacol Exp Ther; 1994 Aug; 270(2):681-9. PubMed ID: 8071859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin and its receptors in non-mammalian vertebrates.
    Conlon JM
    Regul Pept; 1999 Feb; 79(2-3):71-81. PubMed ID: 10100919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen.
    Hilgenfeldt U; Stannek C; Lukasova M; Schnölzer M; Lewicka S
    Br J Pharmacol; 2005 Dec; 146(7):958-63. PubMed ID: 16231010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
    Campbell DJ
    Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.
    Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
    Br J Pharmacol; 2006 Jul; 148(6):825-32. PubMed ID: 16770319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
    Marcondes S; Antunes E
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
    Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.
    Linz W; Wiemer G; Schölkens BA
    Am J Cardiol; 1997 Aug; 80(3A):118A-123A. PubMed ID: 9293964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical distributions of the tissue kallikrein-kinin system in ischemic and non-ischemic mouse heart.
    Yano Y; Ozono R; Nakashima H; Oishi Y; Kambe M; Hosoi K; Oshima T
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S49-53. PubMed ID: 14871029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
    Shimamoto K; Matsuki T; Iimura O
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new kinin moiety in human plasma kininogens.
    Mindroiu T; Carretero OA; Proud D; Walz D; Scicli AG
    Biochem Biophys Res Commun; 1988 Apr; 152(2):519-26. PubMed ID: 3365237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.